Generation of aggrecan-CreERT2 knockin mice for inducible Cre activity in adult cartilage

Genesis

Volumn 47, Issue 12, 2009, Pages 805-814

  Henry, Stephen P ^a   Jang, Chuan Wei ^b   Deng, Jian Min ^a   Zhang, Zhaoping ^a   Behringer, Richard R ^a,b   De Crombrugghe, Benoit ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Aggrecan; Cartilage; CreERT2; Inducible conditional; Mouse technology

Indexed keywords

AGGRECAN 1TM INTERNAL RIBOSOME ENTRY SEQUENCE CRE RECOMBINASE ERT2 PROTEIN; CELL PROTEIN; CRE RECOMBINASE; INDUCIBLE CRE RECOMBINASE; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; FIBROCARTILAGE; GENE EXPRESSION; GENE FUNCTION; GROWTH PLATE; HOMOLOGOUS RECOMBINATION; INTERVERTEBRAL DISK; KNEE MENISCUS; KNOCKIN MOUSE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; TRACHEA;

AGGRECANS; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; CARTILAGE; EMBRYO, MAMMALIAN; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GROWTH PLATE; HISTOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; INTEGRASES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, TRANSGENIC; PREGNANCY; TAMOXIFEN;

MUS;

EID: 73649135324     PISSN: 1526954X     EISSN: 1526968X     Source Type: Journal    
DOI: 10.1002/dvg.20564     Document Type: Article

References (25)

1. Bruckner G, Grosche J, Hartlage-Rubsamen M, Schmidt S, Schachner M. 2003. Region and lamina-specific distribution of extracellular matrix proteoglycans, hyaluronan and tenascin-R in the mouse hippocampal formation. J Chem Neuroanat 26:37-50.
2. Chambers MG, Kuffner T, Cowan SK, Cheah KS, Mason RM. 2002. Expression of collagen and aggrecan genes in normal and osteoarthritic murine knee joints. Osteoarthritis Cartilage 10:51-61.
3. Chen M, Lichtler AC, Sheu TJ, Xie C, Zhang X, O'Keefe RJ, Chen D. 2007. Generation of a transgenic mouse model with chondrocyte-specific and tamoxifen-inducible expression of Cre recombinase. Genesis 45:44-50.
4. Costa C, Tortosa R, Domenech A, Vidal E, Pumarola M, Bassols A. 2007. Mapping of aggrecan, hyaluronic acid, heparan sulphate proteoglycans and aquaporin 4 in the central nervous system of the mouse. J Chem Neuroanat 33:111-123.
5. George SH, Gertsenstein M, Vintersten K, Korets-Smith E, Murphy J, Stevens ME, Haigh JJ, Nagy A. 2007. Developmental and adult phenotyping directly from mutant embryonic stem cells. Proc Natl Acad Sci USA 104:4455-4460.
6. Glumoff V, Savontaus M, Vehanen J, Vuorio E. 1994. Analysis of aggrecan and tenascin gene expression in mouse skeletal tissues by northern and in situ hybridization using species specific cDNA probes. Biochim Biophys Acta 1219:613-622.
7. Grover J, Roughley PJ. 2006. Generation of a transgenic mouse in which Cre recombinase is expressed under control of the type II collagen promoter and doxycycline administration. Matrix Biol 25:158-165.
8. Hayashi S, McMahon AP. 2002. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: A tool for temporally regulated gene activation/inactivation in the mouse. Dev Biol 244:305-318.
9. Indra AK, Warot X, Brocard J, Bornert JM, Xiao JH, Chambon P, Metzger D. 1999. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: Comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res 27:4324-4327.
10. Karsenty G. 2008. Transcriptional control of skeletogenesis. Annu Rev Genomics Hum Genet 9:183-196.
11. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D. 2002. The human genome browser at UCSC. Genome Res 12:996-1006.
12. Kronenberg HM. 2006. PTHrP and skeletal development. Ann N Y Acad Sci 1068:1-13.
13. Lakso M, Sauer B, Mosinger B Jr, Lee EJ, Manning RW, Yu SH, Mulder KL, Westphal H. 1992. Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci USA 89:6232-6236.
14. Leone DP, Genoud S, Atanasoski S, Grausenburger R, Berger P, Metzger D, Macklin WB, Chambon P, Suter U. 2003. Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cells. Mol Cell Neurosci 22:430-440.
15. Mansour SL, Thomas KR, Capecchi MR. 1988. Disruption of the protooncogene int-2 in mouse embryo-derived stem cells: A general strategy for targeting mutations to non-selectable genes. Nature 336:348-352.
16. Nakamura E, Nguyen MT, Mackem S. 2006. Kinetics of tamoxifen-regulated Cre activity in mice using a cartilage-specific CreER(T) to assay temporal activity windows along the proximodistal limb skeleton. Dev Dyn 235:2603-2612.
17. Nakashima K, de Crombrugghe B. 2003. Transcriptional mechanisms in osteoblast differentiation and bone formation. Trends Genet 19:458-466.
18. Orban PC, Chui D, Marth JD. 1992. Tissue- and site-specific DNA recombination in transgenic mice. Proc Natl Acad Sci USA 89:6861-6865.
19. Pedram M, Sprung CN, Gao Q, Lo AW, Reynolds GE, Murnane JP. 2006. Telomere position effect and silencing of transgenes near telomeres in the mouse. Mol Cell Biol 26:1865-1878.
20. Soriano P. 1999. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 21:70-71.
21. Williams A, Harker N, Ktistaki E, Veiga-Fernandes H, Roderick K, Tolaini M, Norton T, Williams K, Kioussis D. 2008. Position effect variegation and imprinting of transgenes in lymphocytes. Nucleic Acids Res 36:2320-2329.
22. Zhang Y, Sun Z, Liu J, Guo X. 2008. Advances in susceptibility genetics of intervertebral degenerative disc disease. Int J Biol Sci 4:283-290.
23. Zhou G, Garofalo S, Mukhopadhyay K, Lefebvre V, Smith CN, Eberspaecher H, de Crombrugghe B. 1995. A 182 bp fragment of the mouse pro alpha 1(II) collagen gene is sufficient to direct chondrocyte expression in transgenic mice. J Cell Sci 108(Pt 12):3677-3684.
24. Zhu M, Chen M, Lichtler AC, O'Keefe RJ, Chen D. 2008a. Tamoxifen-inducible Cre-recombination in articular chondrocytes of adult Col2a1-CreER(T2) transgenic mice. Osteoarthritis Cartilage 16:129-130.
25. Zhu M, Chen M, Zuscik M, Wu Q, Wang YJ, Rosier RN, O'Keefe RJ, Chen D. 2008b. Inhibition of beta-catenin signaling in articular chondrocytes results in articular cartilage destruction. Arthritis Rheum 58:2053-2064.